Birchbrook’s CVS Health CVS Stock Holding History

Birchbrook’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$366K	Buy	4,268 +3	+0.1%	+$294	0.18%	63
2026 Q2	$441K	Sell	4,265 -1,256	-23%	-$112K	0.21%	62
2026 Q1	$396K	Sell	5,521 -144	-3%	-$11.1K	0.19%	59
2025 Q4	$450K	Sell	5,665 -369	-6%	-$29.1K	0.22%	56
2025 Q3	$455K	Buy	6,034 +239	+4%	+$16.4K	0.24%	55
2025 Q2	$400K	Buy	5,795 +288	+5%	+$18.9K	0.21%	56
2025 Q1	$373K	Sell	5,507 -713	-11%	-$42.7K	0.21%	55
2024 Q4	$279K	Sell	6,220 -4,019	-39%	-$225K	0.16%	55
2024 Q3	$644K	Buy	10,239 +146	+1%	+$8.52K	0.36%	46
2024 Q2	$596K	Sell	10,093 -2	-0%	-$125	0.36%	46
2024 Q1	$805K	Sell	10,095 -578	-5%	-$44.2K	0.48%	41
2023 Q4	$843K	Buy	+10,673	New	+$760K	0.56%	40

Other funds holding CVS

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Birchbrook's CVS Position: Q3 2026 in Review

Birchbrook increased its CVS Health (CVS) stake by 0.07% in Q3 2026, buying an estimated $294 and bringing the position to 4,268 shares worth $366K. The position accounts for 0.18% of the portfolio, ranked #63.

Birchbrook first reported a position in CVS in Q4 2023 and has held it in 12 quarters since. The position peaked at $843K in Q4 2023. 808 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

Birchbrook held 4,268 shares of CVS Health worth $366K as of Q3 2026.
Birchbrook bought 3 CVS Health shares in Q3 2026, an estimated $294.
CVS Health made up 0.18% of Birchbrook's portfolio in Q3 2026, its #63 holding.
Birchbrook first reported a position in CVS Health in Q4 2023 and has held it in 12 quarters since.
Birchbrook's CVS Health position peaked at $843K in Q4 2023.
808 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.